LONP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62592161956354E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.32149965917472E-10 |
Normal-vs-Stage2 |
5.62519999999234E-05 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.64024349658121E-12 |
Stage1-vs-Stage2 |
6.250400E-01 |
Stage1-vs-Stage3 |
2.355400E-04 |
Stage1-vs-Stage4 |
3.763200E-04 |
Stage2-vs-Stage3 |
7.556500E-02 |
Stage2-vs-Stage4 |
4.338100E-02 |
Stage3-vs-Stage4 |
6.806600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.626032641866E-12 |
Normal-vs-AfricanAmerican |
2.34550000000056E-05 |
Normal-vs-Asian |
5.602700E-03 |
Caucasian-vs-AfricanAmerican |
9.916800E-01 |
Caucasian-vs-Asian |
7.953600E-01 |
AfricanAmerican-vs-Asian |
8.527600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
3.70359964918521E-10 |
Male-vs-Female |
2.433600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.02700000000644E-05 |
Normal-vs-Age(41-60Yrs) |
6.6927019481966E-11 |
Normal-vs-Age(61-80Yrs) |
1.62481139653892E-12 |
Normal-vs-Age(81-100Yrs) |
1.35509999887873E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.439200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.863800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.085400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.985800E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.214360E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.570000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.598200E-02 |
Normal-vs-Grade 2 |
3.78619358087917E-12 |
Normal-vs-Grade 3 |
1.88071780371502E-13 |
Normal-vs-Grade 4 |
1.62536650805123E-12 |
Grade 1-vs-Grade 2 |
1.607170E-01 |
Grade 1-vs-Grade 3 |
1.128750E-01 |
Grade 1-vs-Grade 4 |
3.079400E-03 |
Grade 2-vs-Grade 3 |
2.697800E-01 |
Grade 2-vs-Grade 4 |
3.015800E-04 |
Grade 3-vs-Grade 4 |
1.406290E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.46209999662972E-09 |
Normal-vs-ccB subtype |
2.5191959629467E-11 |
ccA subtype-vs-ccB subtype |
1.494820E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.32986979603811E-13 |
Normal-vs-N1 |
1.517400E-03 |
N0-vs-N1 |
2.534400E-01 |
|
|